This inventor holds 2 USPTO granted patents and 4 published patent applications. Top assignee: Otsuka Pharmaceutical. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Yanlin Wang: Inventor in Pharmaceutical Treatment Methods.
Introduction
Yanlin Wang is an inventor based in Jersey City, New Jersey, whose patent work includes methods for initiating aripiprazole treatment. He is associated with Otsuka Pharmaceutical and is credited with 2 patents.
Latest Patents
Wang’s listed patent, “Methods for Dose Initiation of Aripiprazole Treatments,” describes a first-day treatment approach for patients who need aripiprazole. The method involves two separate intramuscular injections of an aripiprazole depot formulation, each containing 100 to 500 mg, administered at separate gluteal and/or deltoid injection sites, along with a single oral dose of aripiprazole.
Career Highlights
Wang’s patent activity reflects work on pharmaceutical treatment methods, particularly the initiation of aripiprazole therapy. The available information associates him with Otsuka Pharmaceutical.
Collaborations
Matthew Harlin and Xiaofeng Wang are identified as Wang’s coworkers. The provided information does not specify their roles in the patent or the treatment method.
Conclusion
Yanlin Wang’s listed patent work focuses on a dose-initiation method combining injectable depot and oral aripiprazole, highlighting his contributions to pharmaceutical treatment innovation.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile